Scarica l'app Stockscreener
0.9654
8.84%
0.0784
Dopo l'orario di chiusura:
.93
-0.0354
-3.67%
Precedente Chiudi:
$0.887
Aprire:
$0.88
Volume 24 ore:
193.39K
Relative Volume:
1.23
Capitalizzazione di mercato:
$18.88M
Reddito:
$411.00K
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-2.1941
EPS:
-0.44
Flusso di cassa netto:
$-4.88M
1 W Prestazione:
+8.47%
1M Prestazione:
+10.33%
6M Prestazione:
-20.21%
1 anno Prestazione:
-71.94%
Intervallo 1D:
$0.8706
$0.9656
Intervallo di 1 settimana:
$0.8571
$0.9656
Portata 52W:
$0.7749
$3.72
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Nome
Lexaria Bioscience Corp
Settore
Industria
Telefono
250-765-6424
Indirizzo
100 - 740 MCCURDY ROAD, KELOWNA
Confronta LEXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.9654 | 17.33M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexaria Bioscience Corp Borsa (LEXX) Ultime notizie
Will Lexaria Bioscience Corp. Equity Warrant see short term momentum2025 Earnings Surprises & Daily Stock Trend Reports - Newser
Lexaria Bioscience Corp.’s volatility index tracking explainedTrade Risk Report & Risk Controlled Daily Plans - Newser
What machine learning models say about Lexaria Bioscience Corp. Equity WarrantJuly 2025 Update & Community Supported Trade Ideas - Newser
Full technical analysis of Lexaria Bioscience Corp. stockBuy Signal & Fast Moving Stock Watchlists - Newser
Multi factor analysis applied to Lexaria Bioscience Corp.2025 Fundamental Recap & Daily Technical Forecast Reports - Newser
Can momentum traders help lift Lexaria Bioscience Corp.Portfolio Value Report & Low Drawdown Trading Strategies - Newser
Is Lexaria Bioscience Corp. Equity Warrant forming a bottoming baseInflation Watch & Fast Exit and Entry Strategy Plans - Newser
What institutional flow reveals about Lexaria Bioscience Corp. Equity WarrantGap Down & AI Driven Stock Reports - Newser
Analyzing Lexaria Bioscience Corp. Equity Warrant with multi timeframe chartsEarnings Overview Summary & Consistent Return Strategy Ideas - Newser
Applying chart zones and confluence areas to Lexaria Bioscience Corp.Sell Signal & Capital Efficiency Focused Ideas - Newser
Multi asset correlation models including Lexaria Bioscience Corp.Trade Entry Report & Risk Adjusted Swing Trade Ideas - Newser
Real time scanner hits for Lexaria Bioscience Corp. Equity Warrant explained2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser
Key metrics from Lexaria Bioscience Corp. Equity Warrant’s quarterly dataQuarterly Market Summary & Verified Momentum Stock Alerts - Newser
Will Lexaria Bioscience Corp. Equity Warrant benefit from macro trends2025 Technical Patterns & Growth Focused Stock Pick Reports - Newser
How sentiment analysis helps forecast Lexaria Bioscience Corp. Equity WarrantJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Detecting price anomalies in Lexaria Bioscience Corp. with AIWeekly Risk Summary & AI Enhanced Trading Signals - Newser
Using R and stats models for Lexaria Bioscience Corp. Equity Warrant forecastingEarnings Risk Summary & Weekly Setup with High ROI Potential - Newser
Is this a good reentry point in Lexaria Bioscience Corp. Equity Warrant2025 Macro Impact & Consistent Income Trade Ideas - Newser
Will Lexaria Bioscience Corp. Equity Warrant rebound enough to break even2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Sector ETF performance correlation with Lexaria Bioscience Corp. Equity WarrantPortfolio Gains Report & Daily Risk Controlled Trade Plans - Newser
What analysts say about Lexaria Bioscience Corp. stockTrade Risk Summary & Weekly Top Performers Watchlists - khodrobank.com
Regression analysis insights on Lexaria Bioscience Corp. Equity Warrant performanceWeekly Market Report & Risk Controlled Daily Trade Plans - Newser
Will Lexaria Bioscience Corp. Equity Warrant benefit from geopolitical trends2025 Key Highlights & Free Daily Entry Point Trade Alerts - khodrobank.com
Comparing Lexaria Bioscience Corp. in custom built stock radarsWeekly Trend Recap & AI Powered Trade Plan Recommendations - Newser
Is it too late to sell Lexaria Bioscience Corp.Weekly Investment Report & Community Verified Swing Trade Signals - Newser
What earnings revisions data tells us about Lexaria Bioscience Corp. Equity WarrantDip Buying & Long-Term Capital Growth Strategies - Newser
Applying chart zones and confluence areas to Lexaria Bioscience Corp. Equity WarrantBreakout Watch & Comprehensive Market Scan Reports - Newser
How hedge fund analytics apply to Lexaria Bioscience Corp. Equity Warrant stock2025 Key Highlights & Safe Entry Zone Tips - Newser
Can Lexaria Bioscience Corp. recover in the next quarterDip Buying & Short-Term Trading Alerts - Newser
Can Lexaria Bioscience Corp. be the next market leaderTrade Entry Report & Low Risk Investment Opportunities - khodrobank.com
Best data tools to analyze Lexaria Bioscience Corp. Equity Warrant stock2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Using data filters to optimize entry into Lexaria Bioscience Corp. Equity WarrantNew Guidance & Daily Price Action Insights - Newser
What data driven models say about Lexaria Bioscience Corp.’s futureMarket Activity Report & Free Technical Confirmation Trade Alerts - Newser
Take Profit: What are Lexaria Bioscience Corp.’s technical support levelsMarket Weekly Review & Scalable Portfolio Growth Methods - khodrobank.com
Can Lexaria Bioscience Corp. disrupt its industryWeekly Profit Summary & Technical Buy Zone Confirmations - khodrobank.com
Is Lexaria Bioscience Corp. trending in predictive chart models2025 Bull vs Bear & Daily Volume Surge Signals - Newser
What is Lexaria Bioscience Corp. Equity Warrant s revenue forecastJuly 2025 Intraday Action & Weekly Setup with ROI Potential - khodrobank.com
Will Lexaria Bioscience Corp. benefit from government policyWeekly Stock Summary & Fast Entry Momentum Alerts - khodrobank.com
Is Lexaria Bioscience Corp. a defensive stock2025 Volume Leaders & Community Trade Idea Sharing Platform - khodrobank.com
Update Recap: What are Lexaria Bioscience Corp.’s technical support levelsJuly 2025 Review & Expert Curated Trade Setups - khodrobank.com
What is Lexaria Bioscience Corp. s revenue forecastTreasury Yields & Breakout Confirmation Alerts - khodrobank.com
Insider Buy: What’s the MACD signal for Lexaria Bioscience Corp. Equity WarrantMarket Sentiment Review & Weekly High Conviction Ideas - khodrobank.com
Lexaria Bioscience Corp Azioni (LEXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lexaria Bioscience Corp Azioni (LEXX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BUNKA CHRISTOPHER | Director |
Jul 30 '25 |
Buy |
0.91 |
11,900 |
10,866 |
281,912 |
| McKechnie William Edward | Director |
Jul 29 '25 |
Buy |
0.91 |
5,000 |
4,532 |
18,191 |
| DOCHERTY JOHN MARTIN | President & CSO |
Jul 29 '25 |
Buy |
0.93 |
5,376 |
4,989 |
5,376 |
| Carle Vanessa | Secretary |
Jul 29 '25 |
Buy |
0.91 |
750 |
682 |
750 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Jul 29 '25 |
Buy |
0.91 |
15,000 |
13,641 |
65,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 03 '24 |
Buy |
2.47 |
27,172 |
67,175 |
50,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 02 '24 |
Buy |
2.24 |
22,828 |
51,217 |
22,828 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):